HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
V Trillet-Lenoir Selected Research
V Trillet-Lenoir Research Topics
Disease
6
Neoplasms (Cancer)
04/2015 - 03/2000
5
Breast Neoplasms (Breast Cancer)
02/2011 - 06/2001
4
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
08/2002 - 10/2000
3
Colorectal Neoplasms (Colorectal Cancer)
05/2004 - 08/2000
3
Carcinoma (Carcinomatosis)
10/2003 - 12/2000
2
Cardiotoxicity
02/2011 - 06/2001
2
Nausea
12/2001 - 06/2001
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2001 - 06/2000
2
Vomiting
12/2001 - 06/2001
2
Febrile Neutropenia
06/2001 - 06/2000
2
Adenocarcinoma
09/2000 - 03/2000
1
Drug-Related Side Effects and Adverse Reactions
04/2015
1
Dysphonia (Spastic Dysphonia)
08/2012
1
Epistaxis (Nosebleed)
08/2012
1
Hypertension (High Blood Pressure)
08/2012
1
Proteinuria
08/2012
1
Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational)
03/2007
1
Peritoneal Neoplasms
10/2003
1
Neoplasm Metastasis (Metastasis)
08/2001
1
Alopecia (Baldness)
06/2001
1
Thrombocytopenia (Thrombopenia)
05/2001
1
Rectal Neoplasms (Rectal Cancer)
05/2001
1
Paresthesia (Dysesthesia)
05/2001
1
Pancreatic Neoplasms (Pancreatic Cancer)
09/2000
1
Neutropenia
08/2000
1
Mesodermal Mixed Tumor
03/2000
Drug/Important Bio-Agent (IBA)
4
Fluorouracil (Carac)
FDA Link
Generic
06/2001 - 08/2000
3
Vinorelbine (Navelbine)
FDA Link
Generic
01/2003 - 06/2000
3
Doxorubicin (Adriamycin)
FDA Link
Generic
06/2001 - 10/2000
3
Etoposide (VP 16)
FDA Link
Generic
02/2001 - 10/2000
2
Docetaxel (Taxotere)
FDA Link
02/2011 - 06/2000
2
Trastuzumab (Herceptin)
FDA Link
02/2011 - 03/2007
2
human ERBB2 protein
IBA
02/2011 - 03/2007
2
Irinotecan (Camptosar)
FDA Link
Generic
08/2001 - 08/2000
2
Oxaliplatin (Eloxatin)
FDA Link
Generic
08/2001 - 05/2001
2
Ifosfamide
FDA Link
Generic
02/2001 - 10/2000
1
Pharmaceutical Preparations
IBA
04/2015
1
Antineoplastic Agents (Antineoplastics)
IBA
04/2015
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
08/2012
1
Carboplatin (JM8)
FDA Link
Generic
02/2011
1
Anthracyclines
IBA
02/2011
1
Monoclonal Antibodies
IBA
03/2007
1
Carcinoembryonic Antigen
IBA
05/2004
1
Colony-Stimulating Factors (Colony Stimulating Factor)
IBA
08/2002
1
Antiemetics
IBA
12/2001
1
Chromogranin A
IBA
11/2001
1
Phosphopyruvate Hydratase (Enolase)
IBA
11/2001
1
Epirubicin (Ellence)
FDA Link
Generic
06/2001
1
Mitoxantrone (Novantrone)
FDA Link
Generic
06/2001
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
06/2001
1
R 97
IBA
05/2001
1
Leucovorin (Folinic Acid)
FDA Link
05/2001
1
Therapeutic Uses
IBA
02/2001
1
Cisplatin (Platino)
FDA Link
Generic
12/2000
1
Biological Products
IBA
10/2000
1
Coffee
FDA Link
10/2000
1
Gemcitabine
FDA Link
09/2000
1
Creatinine
IBA
08/2000
1
Bilirubin
IBA
08/2000
1
Platinum
IBA
03/2000
1
Tamoxifen
FDA Link
Generic
03/2000
Therapy/Procedure
16
Drug Therapy (Chemotherapy)
03/2007 - 03/2000
3
Therapeutics
02/2011 - 03/2000
2
Combination Drug Therapy (Combination Chemotherapy)
09/2000 - 06/2000
1
Neoadjuvant Therapy
02/2011
1
Cytoreduction Surgical Procedures
10/2003
1
Operative Surgical Procedures
10/2003
1
Chemoradiotherapy
05/2001
1
Colostomy
05/2001
1
Radiotherapy
05/2001